Medical Imaging (MEDD) 10-Q 13 Nov 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Nov. 10, 2014
Document And Entity Information	'	'
Entity Registrant Name	'MEDICAL IMAGING CORP.	'
Entity Central Index Key	'0001370804	'
Document Type	'10-Q	'
Document Period End Date	30-Sep-14	'
Amendment Flag	'false	'
Current Fiscal Year End Date	'--12-31	'
Is Entity a Well-known Seasoned Issuer?	'No	'
Is Entity a Voluntary Filer?	'No	'
Is Entity's Reporting Status Current?	'Yes	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	23,946,481
Document Fiscal Period Focus	'Q3	'
Document Fiscal Year Focus	'2014	'

Consolidated_Balance_Sheets_Un

Consolidated Balance Sheets (Unaudited) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Current Assets	'	'
Cash and Cash Equivalents	$74,315	$77,300
Accounts Receivable, net	443,807	295,614
Prepaid Expenses	34,495	5,364
Total Current Assets	552,617	378,278
Property and Equipment	'	'
Equipment	1,805,459	1,437,464
Less: Accumulated Depreciation	-364,165	-237,763
Total Property and Equipment, net	1,441,294	1,199,701
Intangibles	'	'
Hospital Contracts	0	794,707
Non-Compete Contract	133,245	133,245
Less: Accumulated Amortization	-133,245	-905,027
Total Intangible Assets, net	0	22,925
Goodwill	1,422,670	1,422,670
Other Assets	'	'
Deposits	32,615	12,855
Loans Receivable	1,786	2,046
Total Other Assets	34,401	14,901
TOTAL ASSETS	3,450,982	3,038,475
Current Liabilities	'	'
Accounts Payable	424,891	250,099
Accrued Taxes Payable	298,660	358,052
Obligations Under Capital Lease, short term portion	123,149	102,210
Acquisition Liability	0	200,000
Promissory Notes, short term portion	79,543	27,543
Convertible Notes, net short term portion	54,070	0
Total Current Liabilities	980,313	937,904
Long Term Liabilities	'	'
Obligations Under Capital Lease, long term portion	216,276	228,495
Promissory Notes, long-term portion	7,749	17,472
Convertible Notes, net, long term portion	2,276,927	1,856,869
Total Long Term Liabilities	2,500,952	2,102,836
Total Liabilities	3,481,265	3,040,740
Stockholders' Equity (Deficit)	'	'
Preferred Stock	0	0
Common Stock	23,897	23,422
Additional Paid-In Capital	1,873,909	1,837,079
Accumulated Other Comprehensive Gain	6,771	6,708
Accumulated Deficit	-1,934,860	-1,869,474
Total Stockholders' Equity (Deficit)	-30,283	-2,265
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	$3,450,982	$3,038,475

Consolidated_Balance_Sheets_Pa

Consolidated Balance Sheets (Parenthetical) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Statement of Financial Position [Abstract]	'	'
Preferred stock, par value in dollars	$0.00	$0.00
Preferred stock, shares authorized	5,000,000	5,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value in dollars	$0.00	$0.00
Common stock, shares authorized	500,000,000	500,000,000
Common stock, shares issued	23,896,481	23,421,481
Common stock, shares outstanding	23,896,481	23,421,481

Consolidated_Statements_of_Ope

Consolidated Statements of Operations (Unaudited) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Revenue:	'	'	'	'
Sales	$1,275,341	$1,322,026	$3,787,403	$3,814,871
Less: Cost of Sales	711,346	820,487	2,212,967	2,390,607
Gross Margin	563,995	501,539	1,574,436	1,424,264
Operating Expenses:	'	'	'	'
Advertising	8,290	19,792	42,543	35,984
Amortization	0	34,387	22,925	103,160
Depreciation	50,252	39,831	129,907	118,753
Bad Debt Expense (Recapture)	-515	-20,455	14,465	1,283
General and Administrative	94,332	65,335	202,829	170,264
Insurance	10,724	12,045	33,832	35,295
Labor	221,148	172,752	597,412	522,327
Legal and Professional	40,322	25,801	138,400	116,063
Management Fees	4,778	3,727	13,866	11,442
Rent Office Space and Servers	39,534	31,698	113,256	92,804
Travel	4,697	10,265	31,167	29,862
Total Operating Expenses	473,562	395,178	1,340,602	1,237,237
Income from Operations	90,433	106,361	233,834	187,027
Other Income and (Expenses):	'	'	'	'
Other Income	512	1,317	715	1,631
Debt Settlement Loss	0	0	0	-607
Foreign Currency Gains (Losses)	145	171	954	4,440
Amortization of Debt Discount	-23,287	-20,356	-66,283	-59,519
Interest Expense	-89,036	-78,835	-239,728	-225,261
Total Other Income (Expenses)	-111,666	-97,703	-304,342	-279,316
Income (Loss) Before Provision for Income Taxes (Credit)	-21,233	8,658	-70,508	-92,289
Provision for Income Taxes	5,122	0	5,122	0
Net Income (Loss)	-16,111	8,658	-65,386	-92,289
Comprehensive Income (Loss)	334	-1,068	63	2,222
Total Comprehensive Income (Loss)	($15,777)	$7,590	($65,323)	($90,067)
Basic and Diluted Income (Loss) per Share	($0.00)	$0	($0.00)	($0.00)
Weighted Average Shares Outstanding - Basic and Diluted	23,850,828	23,421,481	23,688,366	23,326,973

Consolidated_Statements_of_Cas

Consolidated Statements of Cash Flows (Unaudited) (USD $)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:	'	'
Net Income (Loss)	($65,386)	($92,289)
Adjustments to Reconcile Net Loss to Net Cash provided by Operating Activities:	'	'
Depreciation	129,907	118,753
Asset Write Off	961	0
Accrued Interest Converted into note	209,078	182,953
Amortization of Debt Discount	66,283	59,519
Shares issued for services	150	0
Amortization of Intangible Assets	22,925	103,160
Foreign currency transaction Gain/ Loss	498	-4,033
Changes in operating assets and liabilities:	'	'
Accounts Receivable	-148,193	79,842
Deposits and prepaid expenses	-29,131	1,001
Accounts Payable and accrued liabilities	115,400	-108,448
Loans Receivable	260	415
NET CASH AND CASH EQUIVALENTS PROVIDED BY OPERATING ACTIVITIES	302,752	340,873
CASH FLOWS FROM INVESTING ACTIVITIES:	'	'
Payments on acquisition liability	-110,063	0
Deposit on possible acquisition	-20,000	0
Deposit on equipment	0	0
Equipment Purchase	-372,719	-21,415
NET CASH USED IN INVESTING ACTIVITIES	-502,782	-21,415
CASH FLOWS FROM FINANCING ACTIVITIES	'	'
Proceeds from debt issuance	445,000	156,000
Principal payments on Related Party debt	0	-10,291
Principal payments on debt	-256,738	-312,910
Principal Payments on Capital Lease Obligations	8,720	-192,535
NET CASH AND CASH EQUIVALENTS USED IN FINANCING ACTIVITIES	196,982	-359,736
Gain (Loss) due to foreign currency translation	63	2,222
NET CHANGE IN CASH AND CASH EQUIVALENTS	-2,985	-38,056
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	77,300	107,701
CASH AND CASH EQUIVALENTS AT END OF PERIOD	74,315	69,645
Cash paid during the year for:	'	'
Interest	30,650	42,308
Income Taxes	54,864	39,085
Non-cash financing and investing activities:	'	'
Shares Issued for Convertible Note	37,155	18,600
Acquisition Liability Assigned to Loan Payable	64,937	0
Acquisition Liability Assigned to Promissory Note	$25,000	$0

Organization_and_Summary_of_Si

Organization and Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Organization and Summary of Significant Accounting Policies	'
	Note 1. Organization and Summary of Significant Accounting Policies
	Organization and Basis of Presentation
	Medical Imaging Corp., (“MIC” or the “Company”), formerly: Diagnostic Imaging International Corp. (“DIIC”) a Nevada Corporation was incorporated in 2000. In 2005, the Company developed a business plan for private healthcare opportunities in Canada with the objective of owning and operating private diagnostic imaging clinics. In 2009, the Company purchased Canadian Teleradiology Services Inc., which operates as: Custom Teleradiology Services (“CTS”), CTS provides remote reading of medical diagnostic imaging scans for rural hospitals and clinics. In early 2010, the Company modified its business plan to grow its CTS subsidiary while commencing the acquisition of existing full service imaging clinics located in the United States and exploring the development of new diagnostic imaging technology. In 2012, the Company purchased Schuylkill Open MRI Inc., which operates as: Schuylkill Medical Imaging (“SMI”) an independent diagnostic imaging facility located in Pottsville, Pennsylvania.
	Basis of Presentation
	These consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31.
	Principle of Consolidation
	The consolidated financial statements include the accounts of Medical Imaging, Corp., and our wholly-owned subsidiaries, Custom Teleradiology Services, Inc. and Schuylkill Medical Imaging. Intercompany accounts and transactions have been eliminated in the consolidated financial statements. CTS’ and SMI’s accumulated earnings prior to their acquisition (March 2, 2009 and December 10, 2012, respectively) are not included in the consolidated balance sheet.
	Reclassification of Accounts
	Certain prior period amounts have been reclassified to conform to the September 30, 2014 presentation.
	Use of Estimates and Assumptions
	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities known to exist as of the date the consolidated financial statements are published, and (iii) the reported amount of net sales, expenses and costs recognized during the periods presented. Adjustments made with respect to the use of estimates often relate to improved information not previously available. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of consolidated financial statements; accordingly, actual results could differ from these estimates.
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At September 30, 2014, and December 31, 2013, cash includes cash on hand and cash in the bank.
	Accounts Receivable Credit Risk
	The allowance for doubtful accounts is maintained at a level sufficient to provide for estimated credit losses based on evaluating known and inherent risks in the receivables portfolio.
	Management evaluates various factors including expected losses and economic conditions to predict the estimated realization on outstanding receivables. As of September 30, 2014 and December 31, 2013, the allowance for bad debts was $31,583 and $17,294, respectively.
	Bad debt expense for the nine months ended September 30, 2014 and 2013 was $14,465 and $1,283, respectively.
	Bad debt recapture for the three months ended September 30, 2014 and 2013 was $515 and $20,455, respectively.
	At September 30, 2014 two customers of CTS totalled approximately 33% of the total accounts receivable. As of December 31, 2013, three customers totalled approximately 70% of the total accounts receivable.
	Goodwill and Indefinite Intangible Assets
	The Company follows the provisions of Financial Accounting Standard (“FASB”) Accounting Standards Codification (“ASC”) Topic 350, Goodwill and Other Intangible Assets. In accordance with ASC Topic 350, goodwill, representing the excess of the purchase price and related costs over the value assigned to net tangible and identifiable intangible assets of businesses acquired and accounted for under the purchase method, acquired in business combinations is assigned to reporting units that are expected to benefit from the synergies of the combination as of the acquisition date. Under this standard, goodwill and intangibles with indefinite useful lives are not amortized. The Company assesses goodwill and indefinite-lived intangible assets for impairment annually during the fourth quarter, or more frequently if events and circumstances indicate impairment may have occurred in accordance with ASC Topic 350. If the carrying value of a reporting unit's goodwill exceeds its implied fair value, the Company records an impairment loss equal to the difference. ASC Topic 350 also requires that the fair value of indefinite-lived purchased intangible assets be estimated and compared to the carrying value. The Company recognizes an impairment loss when the estimated fair value of the indefinite-lived purchased intangible assets is less than the carrying value. As of September 30, 2014, the Company has goodwill of $1,422,670 as result of the acquisition of SMI on December 10, 2012. If the implied fair value of goodwill is lower than its carrying amount, goodwill impairment is indicated and goodwill is written down to its implied fair value. Subsequent increases in goodwill value are not recognized in the consolidated financial statements.
	Intangible Assets
	CTS has contracts with various hospitals in the province of Ontario, Canada. These contracts are for specific radiology services to be provided for a length of time. Contracts varied between one and five years. The contracts do not specify any minimum billings for any period of time. The contracts in existence on acquisition were valued on acquisition using a discounted cash flow model and the fair value as recorded is amortized over the remaining life of the contract using the straight line method.
	The Company has written off the hospital contracts to reflect end of service with no potential for renewal.
	The Company also attributed value to the non-compete agreement obtained as part of the acquisition agreement with CTS’ former director. As of September 30, 2014. The value attributed to this agreement has been fully amortized.
	SMI has a non-compete agreement with previous owners of SMI. The value attributed to this agreement has been fully amortized.
	Amortization of Intangible Assets
	The accumulated amortization of intangible assets with finite useful lives was $133,245 and $905,027 at September 30, 2014 and December 31, 2013, respectively.
	These assets have been fully amortized; therefore there is no expected amortization expense for the next five years.
	Revenue Recognition
	The Company holds contracts with several hospitals and groups of health care facilities to provide Teleradiology services for a specific period of time. The Company bills for services rendered on a monthly basis. For the quarter ended September 30, 2014, CTS held six contracts; one contract that is renewable on a year-to-year basis, three contracts that are renewable in 2014 ,2015, and 2016, and its largest contract, which renewed automatically in 2013 for successive one year terms. As described above, in accordance with the requirement of Staff Accounting Bulletin (“SAB”) 104, the Company recognizes revenue when: (1) persuasive evidence of an arrangement exists (contracts); (2) delivery has occurred (monthly); (3) the seller’s price is fixed or determinable (per the customer’s contract, and services performed); and (4) collectability is reasonably assured (based upon our credit policy).
	Revenue is accounted for under the guidelines established by SAB 101, Revenue Recognition in Financial Statements, and ASC Topic 605-45, Revenue Recognition – Principal Agent Considerations. For CTS, the Company has the following indicators of gross revenue reporting: (1) CTS is the primary obligator in the provision of services to the Hospitals under contract, (2) CTS has latitude in establishing price, and negotiating contracts with each hospital, (3) CTS negotiates and determines the service specification to be provided to each hospital client, (4) CTS has complete discretion in supplier selection, and (5) CTS has the credit risk. Accordingly, the Company records CTS revenue at gross.
	For SMI, revenue is recorded at the time of service.
	Cost of Sales
	Cost of sales includes fees paid to radiologists for teleradiology services, transcription fees, equipment repairs, system license and usage costs.
	Impairment of Long-Lived Assets
	In accordance with ASC Topic 360, Property, Plant and Equipment, property, plant, and equipment, and purchased intangibles are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.
	Amortization and Depreciation
	Depreciation and amortization are calculated using the straight-line method over the following useful lives:
	3 - 7 years       Equipment
	5 – 7 years      Furniture and Fixtures
	2 to 5 years     Hospital Contracts
	3 - 5 years       Non-compete Contract
	39 years           Leasehold Improvements
	Stock Based Compensation
	The Company measures all share-based payments to employees (which includes non-employee Board of Directors), including employee stock options, warrants and restricted stock, at the fair value of the award and expenses it over the requisite service period (generally the vesting period). The fair value of common stock options or warrants granted to employees is estimated at the date of grant using the Black-Scholes option pricing model. The calculation also takes into account the common stock fair market value at the grant date, the exercise price, the expected life of the common stock option or warrant, the dividend yield and the risk-free interest rate.
	The Company from time to time may issue stock options, warrants and restricted stock to acquire goods or services from third parties. Restricted stock, options or warrants issued to other than employees or directors are recorded on the basis of their fair value. The options or warrants are valued using the Black-Scholes option pricing model on the basis of the market price of the underlying equity instrument on the “valuation date,” which for options and warrants related to contracts that have substantial disincentives to non-performance, is the date of the contract, and for all other contracts is the vesting date. Expenses related to the options and warrants are recognized on a straight-line basis over the period which services are to be received.
	The Company did not recognize stock-based compensation expenses from stock granted to non-employees for the nine and three months ended September 30, 2014 and 2013.
	The Company recognized stock-based compensation expenses of $150, and $0 from stock granted to employees for the nine months ended September 30, 2014, and 2013, respectively.
	The Company did not recognize stock-based compensation expenses from stock granted to employees for the three months ended September 30, 2014 and 2013.
	Fair Value of Financial Instruments
	The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties other than in a forced sale or liquidation.
	The carrying amounts of the Company’s financial instruments, including cash, accounts receivable, prepaid expenses, accounts payable, accrued liabilities and notes and loans payable approximate fair value due to their most maturities.
	Fair Value Measurements
	The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification (“ASC”) for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB ASC (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in U.S. GAAP, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:
	Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
	Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
	Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data.
	The carrying amounts of the Company’s financial assets and liabilities, such as cash and accounts payable approximate their fair values because of the short maturity of these instruments.
	The company does not have assets and liabilities that are carried at fair value on a recurring basis.
	The Company’s functional currency for its wholly-owned subsidiary, CTS, is the Canadian dollar, and their financial statements have been translated into U.S. dollars. The Canadian dollar based accounts of the Company’s foreign operations have been translated into United States dollars using the current rate method. Assets and liabilities of those operations are translated into U.S. dollars using exchange rates as of the balance sheet date; income and expenses are translated using the weighted average exchange rates for the reporting period. Translation adjustments are recorded as accumulated other comprehensive income (loss), a separate component of stockholders’ equity.
	The Company recognized a foreign currency gain on transactions from operations of $954 and $4,440 for the nine months ended September 30, 2014 and 2013, respectively.
	The Company recognized a foreign currency gain on transactions from operations of $145 and $171 for the three months ended September 30, 2014 and 2013, respectively.
The Company recognized other comprehensive gain of $63 and $2,222 for the nine months ended September 30, 2014 and 2013, respectively.
The Company recognized other comprehensive gain of $334 and loss of $1,068 for the three months ended September 30, 2014 and 2013, respectively.
Income Taxes
The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. This statement prescribes the use of the asset and liability method whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.
Net Income (Loss) Per Share
The Company follows the provisions of ASC Topic 260, Earnings per Share. Basic net income (loss) per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Basic and diluted losses per share are the same as all potentially dilutive securities are anti-dilutive.
Basic earnings per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock or conversion of notes into shares of the Company’s common stock that could increase the number of shares outstanding and lower the earnings per share of the Company’s common stock. This calculation is not done for periods in a loss position as this would be antidilutive. As of September 30, 2014, there were no stock options or stock awards that would have been included in the computation of diluted earnings per share that could potentially dilute basic earnings per share in the future.
The information related to basic and diluted earnings per share is as follows:
	Three Months Ending				Nine Months Ending
	September 30,		September 30,		September 30,		September 30,
	2014		2013		2014		2013
Numerator:
Continuing operations:
Total Comprehensive Income (Loss)	$	-15,777	$	7,590	$	-65,323	$	-90,067
Total	$	-15,777	$	7,590	$	-65,323	$	-90,067
Total Comprehensive Income (Loss)	$	-15,777	$	7,590	$	-65,323	$	-90,067
Denominator:
Weighted average number of shares outstanding – basic and diluted		23,850,828		23,421,481		23,688,366		23,326,973
EPS:
Basic:
Total Comprehensive Income (Loss)	$	-0.001	$	0	$	-0.003	$	-0.004
Net Income (loss)	$	-0.001	$	0	$	-0.003	$	-0.004
Diluted
Total Comprehensive Income (Loss)	$	-0.001	$	0	$	-0.003	$	-0.004
Total Comprehensive Income (Loss)	$	-0.001	$	0	$	-0.003	$	-0.004
Recent Accounting Updates
The Company does not expect the adoption of any other recently issued accounting pronouncements to have a significant impact on its results of operations, financial position or cash flow.

Interim_Financial_Statements

Interim Financial Statements	9 Months Ended
	Sep. 30, 2014
Quarterly Financial Information Disclosure [Abstract]	'
Interim Financial Statements	'
	Note 2. Interim Financial Statements
	The accompanying interim unaudited condensed financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In our opinion, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the nine and three month period ended September 30, 2014 are not necessarily indicative of the results that may be expected for the year ending December 31, 2014. For further information, refer to the financial statements and footnotes thereto included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2013.

Property_and_Equipment

Property and Equipment	9 Months Ended
	Sep. 30, 2014
Property, Plant and Equipment [Abstract]	'
Property and Equipment	'
	Note 3. Property and Equipment
	In the quarter ending September 30, 2014, the Company has completed the purchase of a CT and an X-ray machine for its SMI location. SMI has purchased a 16 Slice Toshiba Aquillion CT for $198,000 and a Viztek Digital Direct Radiography Straight Arm x-ray System for $78,250. In addition SMI has completed building CT and x-ray rooms to house the additional machines; the additions in leasehold improvements were for a total of $96,470.
	Property and equipment are stated at cost. Depreciation is calculated on the accelerated method over the estimated useful life of the assets. At September 30, 2014 and December 31, 2013, the major class of property and equipment were as follows:
		September 30,		December 31,		Estimated useful lives
		2014		2013
	Computer/Office Equipment	$	83,654	$	88,378	3-7 years
	Medical Equipment		878,024		601,774	3-7 years
	Leasehold Improvements		843,781		747,312	39 years
	Less: Accumulated Depreciation		-364,165		-237,763
	Net Book Value	$	1,441,294	$	1,199,701
	Depreciation expense was $129,907 and $118,753 for the nine months ended September 30, 2014 and 2013, respectively.
	Depreciation expense was $50,252 and $39,831 for the three months ended September 30, 2014 and 2013, respectively.

Business_Combination

Business Combination	9 Months Ended
	Sep. 30, 2014
Business Combinations [Abstract]	'
Business Combination	'
	Note 4. Business Combination
	SMI acquisition:
	On December 10, 2012, the Company acquired 100% of Schuylkill Medical Imaging for consideration including cash which is described in detail below. Accordingly, the results of operations for SMI have been included in the accompanying consolidated financial statements from that date forward. SMI provides Magnetic Resonance Imaging (MRI) services. Pursuant to the terms of the Share Purchase Agreement, the Company paid an aggregate purchase price of $1,825,000 for the shares, plus a possible earn-out payment of up to $200,000 to be paid within sixty days after December 31, 2013 if certain post-closing revenue targets are met. The earn - out payment was paid out in June 2014.
	In connection with the Share Purchase Agreement, SMI entered into a lease agreement with one of the Sellers for the lease of two MRI machines. Under the terms of the lease, SMI is to make monthly payments of $11,013, plus applicable sales tax, over a period of 48 months. In addition, SMI agreed to make a one-time lease payment of $125,000 which was fully paid by March 30, 2013. The Company has guaranteed all of SMI’s obligations under the lease. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $555,000.
	Consideration for the acquisition comprised the following (at fair value):
	Cash	$	1,825,000
	Acquisition Liability		200,000
	Total consideration paid	$	2,025,000
	Following assets and liabilities were recognized in the acquisition (at fair value):
	Cash	$	42,887
	Accounts receivable		124,436
	Fixed Assets		1,345,647
	Deposits		8,140
	Non-compete agreement		27,917
	Goodwill		1,422,670
	Liabilities assumed		-946,697
	Net assets purchased	$	2,025,000
	The Company has evaluated this transaction and believes that the historical cost of the tangible and intangible assets acquired approximated fair market value given the current nature of the assets acquired. As part of the acquisition the Company has acquired Goodwill of $1,422,670. The Company expects to amortize the full amount of goodwill for tax purposes. At December 31, 2013 year end the Company performed an annual testing of goodwill for impairment, and valued the fair value of the reporting units to be greater than its carrying amount. As such, goodwill impairment was not recorded.
	The amounts of revenue included in the consolidated statement of operations for the nine months ended September 30, 2014 and 2013 is $1,555,083, and $1,371,737, respectively.
	The amounts of gross earnings included in the consolidated statement of operations for nine months ended September 30, 2014 and 2013 is $1,169,591, and $985,272, respectively.
	The amounts of revenue included in the consolidated statement of operations for the three months ended September 30, 2014 and 2013 is $1,696,155, and $1,560,185, respectively.
	The amounts of gross earnings included in the consolidated statement of operations for three months ended September 30, 2014 and 2013 is $441,702, and $345,904, respectively.
	Costs related to the acquisition, which include legal fees, in the amount of $81,811 have been charged directly to operations and are included in legal and professional expenses in the 2012 consolidated statement of operations.
	Prospective Acquisitions:
	On August 28, 2014 the Company entered into a Purchase Agreement to purchase three diagnostic imaging businesses for an aggregate purchase price of $1.8 million. The Company made a refundable deposit of $20,000 to the owner of the businesses, which will be credited against the purchase price at closing. The refundable payment is shown on the consolidated balance sheet as a deposit.
	On October 31, 2014 the Company completed the acquisitions of Partners Imaging Center of Venice LLC, Partners Imaging Center of Charlotte LLC., and Partners Imaging Center of Naples LLC, located in Florida for a purchase price of $1,800,000.

Goodwill

Goodwill	9 Months Ended
	Sep. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Goodwill	'
	Note 5. Goodwill
	The change in the carrying amount of goodwill for the two years ended September 30, 2014 was:
	Balance as of January 1, 2013	$	1,422,670
	Changes in goodwill during the year		-
	Balance as of December 31, 2013		1,422,670
	Changes in goodwill during the year		-
	Balance as of September 30, 2014	$	1,422,670

Lease_Commitments

Lease Commitments	9 Months Ended
	Sep. 30, 2014
Leases, Operating [Abstract]	'
Lease Commitments	'
	Note 6. Leases Commitments
	CTS has a lease commitment for its office space of approximately $2,450 minimum rental, and approximately $2,850 in utilities, realty taxes, and operating costs, for a total of approximately $5,300 per month. The Lease renewed in April 2013 for a period of five years and will expire in March 2018. On renewal, CTS was given a rental credit of approximately $28,000. This lease was accounted for as an operating lease.
	CTS has a lease for its off-site servers at a cost of approximately $1,500 per month. This lease is accounted for as an operating lease. The lease will expire in April 30, 2017.
	SMI has a lease for its off-site servers at a cost of approximately $1,092 per month. This lease is accounted for as an operating lease on a month-to-month basis.
	SMI entered into a lease commitment for its office space in Pottsville, Pennsylvania. The lease will expire on June 30, 2016, and it is renewable for an additional term of 5 years on the same terms and conditions. Monthly rental amounts in 2014 were $5,437 per month plus approximately $1,674 in utilities, realty taxes, and operating costs. The lease was amended to include the additional space of 700 square feet occupied by the CT machine and equipment. The first additional rental payment will begin in July of 2015; the additional rental amount is expected to be approximately $1,100.
	SMI has a lease for office space in Dallas, Texas of approximately $880 per month plus approximately $660 in utilities, realty taxes, and operating costs. The lease will expire in February 28, 2015.
	SMI, has entered into a sublease agreement for approximately one hundred fifty (150) square feet of space for the use of operating the x-ray machine as well as use of common areas of the sublessor. The lease calls for monthly payments of $2,000 beginning October 1, 2014. The lease will expire in October 01, 2021.
	Expected Lease commitments for the next three years:
	Year	Office Space		Servers		Total
	2014	$	47,853	$	7,776	$	55,629
	2015		176,012		18,000		194,012
	2016		179,532		18,000		197,532
		$	403,397	$	43,776	$	447,173

Accounts_Payable_and_Accrued_L

Accounts Payable and Accrued Liabilities	9 Months Ended
	Sep. 30, 2014
Payables and Accruals [Abstract]	'
Accounts Payable and Accrued Liabilities	'
	Note 7. Accounts Payable and Accrued Liabilities
	As of September 30, 2014 and December 31, 2013, the trade payables and accrued liabilities of the Company were $723,551 and $608,151, respectively. Of the total amount as of September 30, 2014, approximately $252,350 is related to CTS operations and $400,551 is related to SMI operations. The balance of the accounts is for vendors supplying goods and services used in the normal course of business. Of the total amount as of December 31, 2013, approximately $301,965 is related to CTS operations and $278,854 is related to SMI operations. The balance of the accounts is for vendors supplying goods and services used in the normal course of business.

Obligations_Under_Capital_Leas

Obligations Under Capital Lease	9 Months Ended
	Sep. 30, 2014
Leases, Capital [Abstract]	'
Obligations Under Capital Lease	'
	Note 8. Obligations Under Capital Lease
	On December 10, 2012, the Company entered into a lease agreement with one of the sellers of SMI to lease the two MRI machines. Under the terms of the lease, SMI is to make monthly payments of $11,013, plus applicable sales tax, over a period of 48 months. In addition, SMI agreed to make a one-time lease payment of $125,000, which was paid by March 30, 2013. The Company has guaranteed all of SMI’s obligations under the lease. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $555,000.
	Minimum future lease payments under the capital lease are as follows as of September 30, 2014:
	2014		33,038
	2015		132,152
	2016		132,151
	Total minimum lease payments		297,341
	Less amount representing interest		33,580
	Present value of minimum lease payments		263,761
	Less current portion of minimum lease payments		109,599
	Long-term capital lease obligations	$	154,162
	The gross amount of the equipment held under capital leases totals $555,000 ($351,583 net book value after accumulated amortization of $203,417) at September 30, 2014.
	Amortization of the capital lease assets is included in the depreciation expense of $83,250, and $27,750 for the nine and three months ending September 30, 2014, respectively.
	On July 03, 2014 Company has entered into a capital lease agreement to lease the x-ray machine that was delivered and installed in July 2014. Under the terms of the lease, the Company’s subsidiary, SMI, is to make monthly payments of $1,495, plus applicable sales tax, over a period of 60 months. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00. The lease was accounted for as a capital lease for a total value of $78,250.
	Minimum future lease payments under the capital lease are as follows as of September 30, 2014:
	2014		4,486
	2015		17,944
	2016		17,944
	2017		17,944
	2018		17,944
	2019		11,963
	Total minimum lease payments		88,225
	Less amount representing interest		12,561
	Present value of minimum lease payments		75,664
	Less current portion of minimum lease payments		13,550
	Long-term capital lease obligations	$	62,114
	The gross amount of the x-ray machine held under the capital lease is $78,250 ($74,337 net book value after accumulated amortization of $3,913) at September 30, 2014.
	Amortization of the capital lease assets is included in the depreciation expense of $3,913, for the nine and three months ending September 30, 2014, respectively.

Promissory_Notes

Promissory Notes	9 Months Ended
	Sep. 30, 2014
Other Liabilities Disclosure [Abstract]	'
Promissory Notes	'
	Note 9. Promissory Notes
	Promissory Notes:
	During the year ended December 31, 2013, $6,616 in accrued interest was recorded on the notes, and $87,225 was paid towards the balance of the notes.$18,736 of the notes assumed on acquisition represented by a promissory note accruing interest at an annual rate of 10.5% and paid out monthly. $45,792 of the notes assumed on acquisition represented by a promissory note accruing interest at an annual rate of 6% and paid out monthly.
	During the nine months ended September 30, 2014, $3,823 in accrued interest was recorded on the notes, and $26,483 was paid towards the balance of the notes.
	In June 2014 $64,937 of the acquisition liability that was due as part of SMI acquisition (see Note 4) was assigned to a promissory note accruing interest at an annual rate of 12%, and due on February 1, 2015. Interest accrued is to be paid out monthly with the principal amount due on maturity.
	A summary of the promissory notes is as follows:
	Promissory notes at January 1, 2013	$	119,624
	Added: Proceeds through December 31, 2013		6,000
	Added: Accrued Interest through December 31, 2013		6,616
	Less: Payments through December 31, 2013		-87,225
	Promissory notes at December 31, 2013	$	45,015
	Added: Note assigned through September 30, 2014		64,937
	Added: Accrued Interest through September 30, 2014		3,823
	Less: Payments through September 30, 2014		-26,483
	Promissory notes at September 30, 2014	$	87,292
	Less: Short term portion		79,543
	Long term portion September 30, 2014	$	7,749

Convertible_Notes

Convertible Notes	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Convertible Notes	'
	Note 10. Convertible Notes
	Series B:
	On December 3, 2012, the Company sold, through a private placement to accredited investors, three year 12% convertible notes (“Series B Notes”) in the aggregate principal amount of $1,865,000. On March 27, 2013 the Company sold an additional $150,000 of Series B Notes.
	Series B Notes pay interest at a rate of 12% per annum, payable to the holder at 1% per month. The Notes are convertible into common shares of the Company at $0.10 per share. In addition, each holder of Series B Notes received shares dependent on the dollar amount of Notes purchased. The total number of shares issued was 5,315,000 shares of common stock of the Company. $1,865,000 of Series B Notes issued on December 3, 2012 mature on December 31, 2013; and $150,000 of Series B Notes issued March 27, 2013 mature on March 31, 2016.
	For the nine month ended September 30, 2014, $181,350 in accrued interest was recorded on the notes and paid.
	In accordance with ASC 470 on issuance of the shares given, the Company recognized additional paid-in capital and a discount against the notes for a total of $244,275. Amortization of the discount for the nine months ended September 30, 2014 was $61,069.
	The Details of Series B Notes are as follows:
	Issuance		December 31,			December 31,			Nine Months			Nine Months			Nine Months			September 30,			Maturity
	Date		2013			2013			Ended			Ended			Ended			2014			Date
			Balance			Unamortized			September 30,			September 30,			September 30,			Balance, net
						Discount			2014			2014			2014
						Beginning			Accrued			(Payments)			Amortization
						Balance			Interest						of Debt
															Discount
	3-Dec-12		$	25,000		$	-719		$	2,250		$	-2,250		$	281		$	24,562		31-Dec-15
	3-Dec-12			125,000			-10,569			11,250			-11,250			3,731			118,162		31-Dec-15
	3-Dec-12			50,000			-2,156			4,500			-4,500			844			48,688		31-Dec-15
	3-Dec-12			25,000			-719			2,250			-2,250			281			24,562		31-Dec-15
	3-Dec-12			25,000			-719			2,250			-2,250			281			24,562		31-Dec-15
	3-Dec-12			25,000			-719			2,250			-2,250			281			24,562		31-Dec-15
	3-Dec-12			1,500,000			-129,375			135,000			-135,000			50,625			1,421,250		31-Dec-15
	3-Dec-12			50,000			-2,156			4,500			-4,500			844			48,688		31-Dec-15
	3-Dec-12			15,000			-431			1,350			-1,350			169			14,738		31-Dec-15
	3-Dec-12			100,000			-7,081			9,000			-9,000			2,569			95,488		31-Dec-15
	27-Mar-13			25,000			-1,162			2,250			-2,250			388			24,226		31-Mar-16
	27-Mar-13			25,000			-1,162			2,250			-2,250			388			24,226		31-Mar-16
	27-Mar-13			25,000			-1,162			2,250			-2,250			388			24,226		31-Mar-16
	Total		$	2,015,000		$	-158,131		$	181,350		$	-181,350		$	61,069		$	1,917,940
	Summary of Series B Notes is as follows:
		September 30,			December 31,
		2014			2013
	Convertible notes Beginning Balance	$	2,015,000		$	2,015,000
	Less: unamortized debt discount		-97,060			-158,131
	Convertible notes principal, net		1,917,940			1,856,869
	Less: Payments in Period		-181,350			-235,300
	Added: Accrued interest		181,350			235,300
	Total Convertible notes, net	$	1,917,940		$	1,856,869
	Less: Short term portion, net		-			-
	Long term portion, net	$	1,917,940		$	1,856,869
	Following are maturities of the long –term debt in Series B Notes for each of the next 5 years:
			Principal			Interest		Amortization
			Payments			Payments		of Discount
	2014		$	-		$	60,450	$	20,357
	2015			1,865,000			241,800		75,155
	2016			150,000			4,500		1,550
	2017			-			-		-
	2018			-			-		-
	Total		$	2,015,000		$	306,750	$	97,062
	Series C:
	On May 22, 2014 the Company sold, through private placement to accredited investors, three year 12% convertible notes (“Series C Notes”) in the aggregate principal amount of $95,000.
	The Notes bear interest at a rate of 12% per annum, payable to the holder at1% per month, with the principal amount due on May 31, 2017. The Notes are convertible into shares of the Company’s common stock at an initial conversion rate of $0.15 per share. In addition, each holder of Series C Notes received shares dependent on the dollar amount of Notes purchased. On August 25, 2014 the company sold an additional $75,000 of “series C notes”. The total number of shares issued was 170,000 shares of common stock of the Company.
	In accordance with ASC 470 on issuance of the shares given, the Company recognized additional paid-in capital and a discount against the notes for a total of $11,655. Amortization of the discount for the nine months ended September 30, 2014, was $964.
	For the nine month ended September 30, 2014, $5,568 in accrued interest was recorded on the notes and paid.
	Issuance		December 31,			Nine Months		September 30,			Nine Months			Nine Months			Nine Months			September 30,		Maturity
	Date		2013			Ended		2014			Ended			Ended			Ended			2014		Date
			Balance			September 30,		Unamortized			September 30,			September 30,			September 30,			Balance, net
						2014		Discount			2014			2014			2014
						Proceeds		Beginning			Accrued			(Payments)			Amortization
									Balance		Interest						of Debt
																	Discount
	22-May-14		$	-		$	50,000	$	-3,000		$	2,141		$	-2,141		$	333		$	47,333	31-May-17
	22-May-14			-			22,500		-1,350			963			-963			150			21,300	31-May-17
	22-May-14			-			22,500		-1,350			963			-963			150			21,300	31-May-17
25-Aug-14			-			50,000		-3,970			1,000			-1,000			221			46,251	31-Oct-17
25-Aug-14			-			25,000		-1,985			500			-500			110			23,125	31-Oct-17
Total		$	-		$	170,000	$	-11,655		$	5,567		$	-5,567		$	964		$	159,309
Summary of Series C Notes is as follows:
	September 30,			December 31,
	2014			2013
Convertible notes Beginning Balance	$	170,000		$	-
Less: unamortized debt discount		-10,691			-
Convertible notes principal, net		159,309			-
Less: Payments in Period		-5,567			-
Added: Accrued interest		5,567			-
Total Convertible notes, net	$	159,309		$	-
Less: Short term portion, net		-			-
Long term portion, net	$	159,309		$	-
Following are maturities of the long –term debt in Series C Notes for each of the next 5 years:
		Principal			Interest		Amortization
		Payments			Payments		of Discount
2014		$	-		$	5,100	$	971
2015			-			17,000		3,885
2016			-			17,000		3,885
2017			170,000			4,750		1,950
2018			-			-		-
Total		$	170,000		$	43,850	$	10,691
Individually issued Convertible Note:
On March 26, 2014 the Company issued $300,000 in convertible note to a non-affiliate. The note pays interest at a rate of 12% per annum, payable to the holder at 1% per month. In addition to interest payments the Company will be making monthly payments of $5,000 towards the principal balance beginning June 1, 2014 for three years until the note due date of February 27, 2017. The note is convertible into common shares of the Company at $0.15 per share. In addition, the non-affiliate will receive 300,000 shares as part of the note agreement.
For the nine month ended September 30, 2014, $18,337 in accrued interest was recorded on the notes and paid.
In accordance with ASC 470 on issuance of the shares given, the Company recognized additional paid-in capital and a discount against the notes for a total of $25,500. Amortization of the discount for the nine months ended September 30, 2014 was $4,250.
Summary of the note is as follows:
	September 30,			December 31,
	2014			2013
Convertible note Beginning Balance	$	300,000		$	-
Less: unamortized debt discount		-21,250			-
Convertible notes principal, net		278,750			-
Less: Payments in Period		-43,337			-
Added: Accrued interest		18,337			-
Total Convertible note, net	$	253,750		$	-
Less: short term portion, net		54,070			-
Long term portion, net	$	199,680		$	-
Following are maturity of the individually issued convertible note for each of the next 5 years:
		Principal			Interest		Amortization
		Payments			Payments		of Discount
2014		$	15,000		$	5,466	$	2,125
2015			60,000			27,884		8,500
2016			60,000			20,748		8,500
2017			140,000			2,625		2,125
2018			-			-		-
Total		$	275,000		$	56,723	$	21,250

Related_Party_Transactions

Related Party Transactions	9 Months Ended
	Sep. 30, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	Note 11. Related Party Transactions
	In 2013, Richard Jagodnik (an officer and shareholder of the Company), had a $7,062 note payable from MIC. The note was non-interest bearing and payable on demand. As at December 31, 2013 the note is fully paid.
	During the second quarter of 2010, Richard Jagodnik loaned MIC $42,944 under the same terms of convertible notes Series A. The note was carried in Canadian dollars and a foreign exchange gain of $693 was recorded for the year ended December 31, 2013. For the year ended December 31, 2013 $48 in accrued interest was recorded and added to the note. As at December 31, 2013 the note was fully paid.
	For the nine months ended September 30, 2014 the Company did not have any related party debt outstanding.
	Summary of related party notes is as follows:
		Shareholder		Shareholder
		Note		Convertible Note
	Balance at January 1, 2013	$	7,062	$	10,936
	Added: Accrued Interest		-		48
	Less: Foreign Exchange Gain		-		693
	Less: Payments		-7,062		-10,291
	Balance at December 31, 2013	$	-	$	-
	Balance at September 30, 2014	$	-	$	-

Major_Customers

Major Customers	9 Months Ended
	Sep. 30, 2014
Major Customers	'
Major Customers	'
	Note 12. Major Customers
	For the nine months ending September 30, 2014 and 2013, revenue was derived primarily from radiology services.
	Major customers representing more than 10% of total revenue for the nine months ended September 30, 2014 and 2013 are as follow:
			Nine Months Ended				Nine Months Ended
			30-Sep-14				30-Sep-13
	Customers		Revenue		Revenue		Revenue		Revenue
			amount		percentage		amount		percentage
	Contract A		$	650,079	17%		$	850,749	22%
	Contract E			698,618	18%			791,039	21%
	Contract F			430,257	11%			427,108	11%
	Contract H		$	247,239	7%		$	206,705	5%
	Closing balances of accounts receivable for our major customers were as follow:
	Balance at				Balance at
	30-Sep-14				31-Dec-13
	Accounts			Accounts	Accounts			Accounts
	Receivable			Receivable	Receivable			Receivable
	Closing Balance			Percentage	Closing Balance			Percentage
	$	-		0%	$	17,876		6%
		100,834		23%		95,552		34%
		45,849		10%		46,796		17%
	$	30,850		7%	$	54,757		19%
	On May 8, 2014, the Company’s wholly-owned subsidiary, CTS, received notice that Contract A of its major customers is terminating its contract (the “Agreement”) with CTS. Pursuant to the terms of the Agreement, such termination is effective 90 days from the date of the notice.

Major_Vendors

Major Vendors	9 Months Ended
	Sep. 30, 2014
Major Vendors	'
Major Vendors	'
	Note 13. Major Vendors
	The Company has one major vendor providing its system software and support. Expenses relating to this vendor for the three months ended September 30, 2014 and 2013 were $14,190 and $14,560, respectively.

Common_Stock_Transactions

Common Stock Transactions	9 Months Ended
	Sep. 30, 2014
Equity [Abstract]	'
Common Stock Transactions	'
	Note 14. Common Stock Transactions
	For the nine months ended September 30, 2014, 5,000 shares were issued for services valued at $150 based upon the closing price of our common stock at the grant date.
	For the nine months ended September 30, 2014, 300,000 shares were issued as part of individually issued convertible note agreement. The shares were valued at $25,500 based upon the closing price of our common stock at the grant date.
	For the nine months ended September 30, 2014, 170,000 shares were issued as part of series C convertible note agreement. The shares were valued at $11,655 based upon the closing price of our common stock at the grant date.
	For the year ended December 31, 2013, 300,000 shares were issued as part of convertible notes agreements. The shares were valued at $18,600 based upon the closing price of our common stock at the grant date.
	For the year ended December 31, 2012 5,015,000 shares were issued as an additional part of convertible notes agreements. The shares were valued at $225,675 based upon the closing price of our common stock at the grant date.

Income_Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	Note 15. Income Tax
	The Company follows ASC 740, Income Taxes, which requires the recognition of deferred tax liabilities and assets for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred tax liabilities and assets are determined based on the difference between consolidated financial statements and tax bases of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.
	The provisions of ASC 740 require companies to recognize in their financial statements the impact of a tax position if that position is more likely than not to be sustained upon audit, based upon the technical merits of the position. ASC 740 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken on a tax return. ASC 740 also provides guidance on de-recognition, classification, interest and penalties, accounting in interim periods and disclosure.
	Management does not believe that the Company has any material uncertain tax positions requiring recognition or measurement in accordance with the provisions of ASC 740. Accordingly, the adoption of these provisions of ASC 740 did not have a material effect on the Company’s financial statements. The Company’s policy is to record interest and penalties on uncertain tax positions, if any, as income tax expense.

Going_Concern

Going Concern	9 Months Ended
	Sep. 30, 2014
Going Concern	'
Going Concern	'
	Note. 16. Going Concern
	As shown in the accompanying consolidated financial statements, the Company incurred net losses of $15,777 for the three months ended September 30, 2014 as well as a working capital deficit of $427,696. These conditions raise substantial doubt as to if the Company’s ability to continue as a going concern. Management plan to raise additional financing in order to continue its operations and fulfil its debt obligations in 2015, but there can be no assurances that the plan will be successful. These consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

Subsequent_Events

Subsequent Events	9 Months Ended
	Sep. 30, 2014
Subsequent Events [Abstract]	'
Subsequent Events	'
	Note 17. Subsequent events
	Subsequent to quarter end, the company issued $50,000 in Series C Notes to a non-affiliate. The Company evaluated subsequent events through the date the consolidated financial statements were issued. In addition, the purchaser of the note will receive 50,000 bonus shares as part of the note agreement.
	Subsequent to quarter end, the company completed the acquisitions of Partners Imaging of Venice, Partners Imaging of Port Charlotte, and Partners Imaging of Naples all located in Florida for a purchase price of $1,800,000. To fund the purchase price, the company entered into a royalty purchase agreement with Grenville Strategic Royalty Corp. and using $2 million of the available credit amount to finance the acquisition, with the remainder as for general working capital purposes.

Accounting_Policies_Policies

Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2014
Accounting Policies [Abstract]	'
Organization and Basis of Presentation	'
	Organization and Basis of Presentation
	Medical Imaging Corp., (“MIC” or the “Company”), formerly: Diagnostic Imaging International Corp. (“DIIC”) a Nevada Corporation was incorporated in 2000. In 2005, the Company developed a business plan for private healthcare opportunities in Canada with the objective of owning and operating private diagnostic imaging clinics. In 2009, the Company purchased Canadian Teleradiology Services Inc., which operates as: Custom Teleradiology Services (“CTS”), CTS provides remote reading of medical diagnostic imaging scans for rural hospitals and clinics. In early 2010, the Company modified its business plan to grow its CTS subsidiary while commencing the acquisition of existing full service imaging clinics located in the United States and exploring the development of new diagnostic imaging technology. In 2012, the Company purchased Schuylkill Open MRI Inc., which operates as: Schuylkill Medical Imaging (“SMI”) an independent diagnostic imaging facility located in Pottsville, Pennsylvania.
	Basis of Presentation
	These consolidated financial statements and related notes are presented in accordance with accounting principles generally accepted in the United States, and are expressed in U.S. dollars. The Company’s fiscal year-end is December 31.
Principle of Consolidation	'
	Principle of Consolidation
	The consolidated financial statements include the accounts of Medical Imaging, Corp., and our wholly-owned subsidiaries, Custom Teleradiology Services, Inc. and Schuylkill Medical Imaging. Intercompany accounts and transactions have been eliminated in the consolidated financial statements. CTS’ and SMI’s accumulated earnings prior to their acquisition (March 2, 2009 and December 10, 2012, respectively) are not included in the consolidated balance sheet.
Reclassification of Accounts	'
	Reclassification of Accounts
	Certain prior period amounts have been reclassified to conform to the September 30, 2014 presentation.
Use of Estimates and Assumptions	'
	Use of Estimates and Assumptions
	The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States (“GAAP”) requires management to make estimates and assumptions that affect (i) the reported amounts of assets and liabilities, (ii) the disclosure of contingent assets and liabilities known to exist as of the date the consolidated financial statements are published, and (iii) the reported amount of net sales, expenses and costs recognized during the periods presented. Adjustments made with respect to the use of estimates often relate to improved information not previously available. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of consolidated financial statements; accordingly, actual results could differ from these estimates.
Cash and Cash Equivalents	'
	Cash and Cash Equivalents
	The Company considers all highly liquid investments with an original maturity of three months or less to be cash equivalents. At September 30, 2014, and December 31, 2013, cash includes cash on hand and cash in the bank.
Accounts Receivable Credit Risk	'
	Accounts Receivable Credit Risk
	The allowance for doubtful accounts is maintained at a level sufficient to provide for estimated credit losses based on evaluating known and inherent risks in the receivables portfolio.
	Management evaluates various factors including expected losses and economic conditions to predict the estimated realization on outstanding receivables.
Goodwill and Indefinite Intangible Assets	'
	Goodwill and Indefinite Intangible Assets
	The Company follows the provisions of Financial Accounting Standard (“FASB”) Accounting Standards Codification (“ASC”) Topic 350, Goodwill and Other Intangible Assets. In accordance with ASC Topic 350, goodwill, representing the excess of the purchase price and related costs over the value assigned to net tangible and identifiable intangible assets of businesses acquired and accounted for under the purchase method, acquired in business combinations is assigned to reporting units that are expected to benefit from the synergies of the combination as of the acquisition date. Under this standard, goodwill and intangibles with indefinite useful lives are not amortized. The Company assesses goodwill and indefinite-lived intangible assets for impairment annually during the fourth quarter, or more frequently if events and circumstances indicate impairment may have occurred in accordance with ASC Topic 350. If the carrying value of a reporting unit's goodwill exceeds its implied fair value, the Company records an impairment loss equal to the difference. ASC Topic 350 also requires that the fair value of indefinite-lived purchased intangible assets be estimated and compared to the carrying value. The Company recognizes an impairment loss when the estimated fair value of the indefinite-lived purchased intangible assets is less than the carrying value. If the implied fair value of goodwill is lower than its carrying amount, goodwill impairment is indicated and goodwill is written down to its implied fair value. Subsequent increases in goodwill value are not recognized in the consolidated financial statements.
Intangible Assets	'
	Intangible Assets
	CTS has contracts with various hospitals in the province of Ontario, Canada. These contracts are for specific radiology services to be provided for a length of time. Contracts varied between one and five years. The contracts do not specify any minimum billings for any period of time. The contracts in existence on acquisition were valued on acquisition using a discounted cash flow model and the fair value as recorded is amortized over the remaining life of the contract using the straight line method.
Revenue Recognition	'
	Revenue Recognition
	The Company holds contracts with several hospitals and groups of health care facilities to provide Teleradiology services for a specific period of time. The Company bills for services rendered on a monthly basis. For the quarter ended September 30, 2014, CTS held six contracts; one contract that is renewable on a year-to-year basis, three contracts that are renewable in 2014 ,2015, and 2016, and its largest contract, which renewed automatically in 2013 for successive one year terms. As described above, in accordance with the requirement of Staff Accounting Bulletin (“SAB”) 104, the Company recognizes revenue when: (1) persuasive evidence of an arrangement exists (contracts); (2) delivery has occurred (monthly); (3) the seller’s price is fixed or determinable (per the customer’s contract, and services performed); and (4) collectability is reasonably assured (based upon our credit policy).
	Revenue is accounted for under the guidelines established by SAB 101, Revenue Recognition in Financial Statements, and ASC Topic 605-45, Revenue Recognition – Principal Agent Considerations. For CTS, the Company has the following indicators of gross revenue reporting: (1) CTS is the primary obligator in the provision of services to the Hospitals under contract, (2) CTS has latitude in establishing price, and negotiating contracts with each hospital, (3) CTS negotiates and determines the service specification to be provided to each hospital client, (4) CTS has complete discretion in supplier selection, and (5) CTS has the credit risk. Accordingly, the Company records CTS revenue at gross.
	For SMI, revenue is recorded at the time of service.
Cost of Sales	'
	Cost of Sales
	Cost of sales includes fees paid to radiologists for teleradiology services, transcription fees, equipment repairs, system license and usage costs.
Impairment of Long-Lived Assets	'
	Impairment of Long-Lived Assets
	In accordance with ASC Topic 360, Property, Plant and Equipment, property, plant, and equipment, and purchased intangibles are reviewed for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. Goodwill and other intangible assets are tested for impairment. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized by the amount by which the carrying amount of the asset exceeds the fair value of the asset.
Amortization and Depreciation	'
	Amortization and Depreciation
	Depreciation and amortization are calculated using the straight-line method over the following useful lives.
Stock Based Compensation	'
	Stock Based Compensation
	The Company measures all share-based payments to employees (which includes non-employee Board of Directors), including employee stock options, warrants and restricted stock, at the fair value of the award and expenses it over the requisite service period (generally the vesting period). The fair value of common stock options or warrants granted to employees is estimated at the date of grant using the Black-Scholes option pricing model. The calculation also takes into account the common stock fair market value at the grant date, the exercise price, the expected life of the common stock option or warrant, the dividend yield and the risk-free interest rate.
	The Company from time to time may issue stock options, warrants and restricted stock to acquire goods or services from third parties. Restricted stock, options or warrants issued to other than employees or directors are recorded on the basis of their fair value. The options or warrants are valued using the Black-Scholes option pricing model on the basis of the market price of the underlying equity instrument on the “valuation date,” which for options and warrants related to contracts that have substantial disincentives to non-performance, is the date of the contract, and for all other contracts is the vesting date. Expenses related to the options and warrants are recognized on a straight-line basis over the period which services are to be received.
Fair Value of Financial Instruments	'
	Fair Value of Financial Instruments
	The fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties other than in a forced sale or liquidation.
	The carrying amounts of the Company’s financial instruments, including cash, accounts receivable, prepaid expenses, accounts payable, accrued liabilities and notes and loans payable approximate fair value due to their most maturities.
Fair Value Measurements	'
	Fair Value Measurements
	The Company follows paragraph 825-10-50-10 of the FASB Accounting Standards Codification (“ASC”) for disclosures about fair value of its financial instruments and paragraph 820-10-35-37 of the FASB ASC (“Paragraph 820-10-35-37”) to measure the fair value of its financial instruments. Paragraph 820-10-35-37 establishes a framework for measuring fair value in U.S. GAAP, and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, Paragraph 820-10-35-37 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three levels of fair value hierarchy defined by Paragraph 820-10-35-37 are described below:
	Level 1 Quoted market prices available in active markets for identical assets or liabilities as of the reporting date.
	Level 2 Pricing inputs other than quoted prices in active markets included in Level 1, which are either directly or indirectly observable as of the reporting date.
	Level 3 Pricing inputs that are generally observable inputs and not corroborated by market data.
	The carrying amounts of the Company’s financial assets and liabilities, such as cash and accounts payable approximate their fair values because of the short maturity of these instruments.
	The company does not have assets and liabilities that are carried at fair value on a recurring basis.
	The Company’s functional currency for its wholly-owned subsidiary, CTS, is the Canadian dollar, and their financial statements have been translated into U.S. dollars. The Canadian dollar based accounts of the Company’s foreign operations have been translated into United States dollars using the current rate method. Assets and liabilities of those operations are translated into U.S. dollars using exchange rates as of the balance sheet date; income and expenses are translated using the weighted average exchange rates for the reporting period. Translation adjustments are recorded as accumulated other comprehensive income (loss), a separate component of stockholders’ equity.
Income Taxes	'
	Income Taxes
	The Company accounts for income taxes in accordance with ASC Topic 740, Income Taxes. This statement prescribes the use of the asset and liability method whereby deferred tax asset and liability account balances are determined based on differences between financial reporting and tax bases of assets and liabilities and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse.
Net Income/ (Loss) Per Share	'
	Net Income (Loss) Per Share
	The Company follows the provisions of ASC Topic 260, Earnings per Share. Basic net income (loss) per share is computed by dividing net loss available to common stockholders by the weighted average number of common shares outstanding during the period. Basic and diluted losses per share are the same as all potentially dilutive securities are anti-dilutive.
	Basic earnings per share is computed by dividing net income available to common shareholders by the weighted average number of common shares outstanding during the period. Diluted earnings per share reflects the potential dilution that could occur if stock options and other commitments to issue common stock were exercised or equity awards vest resulting in the issuance of common stock or conversion of notes into shares of the Company’s common stock that could increase the number of shares outstanding and lower the earnings per share of the Company’s common stock. This calculation is not done for periods in a loss position as this would be antidilutive.
Recent Accounting Updates	'
	Recent Accounting Updates
	The Company does not expect the adoption of any other recently issued accounting pronouncements to have a significant impact on its results of operations, financial position or cash flow.

Organization_and_Summary_of_Si1

Organization and Summary of Significant Accounting Policies (Tables)	9 Months Ended
	Sep. 30, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Schedule of Earnings Per Share	'
		Three Months Ending				Nine Months Ending
		September 30,		September 30,		September 30,		September 30,
		2014		2013		2014		2013
	Numerator:
	Continuing operations:
	Total Comprehensive Income (Loss)	$	-15,777	$	7,590	$	-65,323	$	-90,067
	Total	$	-15,777	$	7,590	$	-65,323	$	-90,067
	Total Comprehensive Income (Loss)	$	-15,777	$	7,590	$	-65,323	$	-90,067
	Denominator:
	Weighted average number of shares outstanding – basic and diluted		23,850,828		23,421,481		23,688,366		23,326,973
	EPS:
	Basic:
	Total Comprehensive Income (Loss)	$	-0.001	$	0	$	-0.003	$	-0.004
	Net Income (loss)	$	-0.001	$	0	$	-0.003	$	-0.004
	Diluted
	Total Comprehensive Income (Loss)	$	-0.001	$	0	$	-0.003	$	-0.004
	Total Comprehensive Income (Loss)	$	-0.001	$	0	$	-0.003	$	-0.004

Property_and_Equipment_Tables

Property and Equipment (Tables)	9 Months Ended
	Sep. 30, 2014
Property, Plant and Equipment [Abstract]	'
Property Plant and Equipment	'
		September 30,		December 31,		Estimated useful lives
		2014		2013
	Computer/Office Equipment	$	83,654	$	88,378	3-7 years
	Medical Equipment		878,024		601,774	3-7 years
	Leasehold Improvements		843,781		747,312	39 years
	Less: Accumulated Depreciation		-364,165		-237,763
	Net Book Value	$	1,441,294	$	1,199,701

Business_Combination_Tables

Business Combination (Tables)	9 Months Ended
	Sep. 30, 2014
Business Combinations [Abstract]	'
Schedule of Purchase Price Allocation	'
	Cash	$	1,825,000
	Acquisition Liability		200,000
	Total consideration paid	$	2,025,000
Schedule of Recognized Assets Acquired and Liabilities Assumed	'
	Cash	$	42,887
	Accounts receivable		124,436
	Fixed Assets		1,345,647
	Deposits		8,140
	Non-compete agreement		27,917
	Goodwill		1,422,670
	Liabilities assumed		-946,697
	Net assets purchased	$	2,025,000

Goodwill_Tables

Goodwill (Tables)	9 Months Ended
	Sep. 30, 2014
Goodwill and Intangible Assets Disclosure [Abstract]	'
Schedule of Goodwill	'
	Balance as of January 1, 2013	$	1,422,670
	Changes in goodwill during the year		-
	Balance as of December 31, 2013		1,422,670
	Changes in goodwill during the year		-
	Balance as of September 30, 2014	$	1,422,670

Lease_Commitments_Tables

Lease Commitments (Tables)	9 Months Ended
	Sep. 30, 2014
Leases, Operating [Abstract]	'
Schedule of Lease Commitments	'
	Year	Office Space		Servers		Total
	2014	$	47,853	$	7,776	$	55,629
	2015		176,012		18,000		194,012
	2016		179,532		18,000		197,532
		$	403,397	$	43,776	$	447,173

Obligations_Under_Capital_Leas1

Obligations Under Capital Lease (Tables)	9 Months Ended
	Sep. 30, 2014
Leases, Capital [Abstract]	'
Schedule of Future Minimum Lease Payments for Capital Leases	'
	MRI Machines
	2014		33,038
	2015		132,152
	2016		132,151
	Total minimum lease payments		297,341
	Less amount representing interest		33,580
	Present value of minimum lease payments		263,761
	Less current portion of minimum lease payments		109,599
	Long-term capital lease obligations	$	154,162
	X-Ray Machine
	2014		4,486
	2015		17,944
	2016		17,944
	2017		17,944
	2018		17,944
	2019		11,963
	Total minimum lease payments		88,225
	Less amount representing interest		12,561
	Present value of minimum lease payments		75,664
	Less current portion of minimum lease payments		13,550
	Long-term capital lease obligations	$	62,114

Promissory_Notes_Tables

Promissory Notes (Tables)	9 Months Ended
	Sep. 30, 2014
Other Liabilities Disclosure [Abstract]	'
Schedule of Promissory Notes	'
	Promissory notes at January 1, 2013	$	119,624
	Added: Proceeds through December 31, 2013		6,000
	Added: Accrued Interest through December 31, 2013		6,616
	Less: Payments through December 31, 2013		-87,225
	Promissory notes at December 31, 2013	$	45,015
	Added: Note assigned through September 30, 2014		64,937
	Added: Accrued Interest through September 30, 2014		3,823
	Less: Payments through September 30, 2014		-26,483
	Promissory notes at September 30, 2014	$	87,292
	Less: Short term portion		79,543
	Long term portion September 30, 2014	$	7,749

Convertible_Notes_Tables

Convertible Notes (Tables)	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Schedule of Debt	'
	Series B
	Issuance		December 31,			December 31,			Nine Months			Nine Months			Nine Months			September 30,			Maturity
	Date		2013			2013			Ended			Ended			Ended			2014			Date
			Balance			Unamortized			September 30,			September 30,			September 30,			Balance, net
						Discount			2014			2014			2014
						Beginning			Accrued			(Payments)			Amortization
						Balance			Interest						of Debt
															Discount
	3-Dec-12		$	25,000		$	-719		$	2,250		$	-2,250		$	281		$	24,562		31-Dec-15
	3-Dec-12			125,000			-10,569			11,250			-11,250			3,731			118,162		31-Dec-15
	3-Dec-12			50,000			-2,156			4,500			-4,500			844			48,688		31-Dec-15
	3-Dec-12			25,000			-719			2,250			-2,250			281			24,562		31-Dec-15
	3-Dec-12			25,000			-719			2,250			-2,250			281			24,562		31-Dec-15
	3-Dec-12			25,000			-719			2,250			-2,250			281			24,562		31-Dec-15
	3-Dec-12			1,500,000			-129,375			135,000			-135,000			50,625			1,421,250		31-Dec-15
	3-Dec-12			50,000			-2,156			4,500			-4,500			844			48,688		31-Dec-15
	3-Dec-12			15,000			-431			1,350			-1,350			169			14,738		31-Dec-15
	3-Dec-12			100,000			-7,081			9,000			-9,000			2,569			95,488		31-Dec-15
	27-Mar-13			25,000			-1,162			2,250			-2,250			388			24,226		31-Mar-16
	27-Mar-13			25,000			-1,162			2,250			-2,250			388			24,226		31-Mar-16
	27-Mar-13			25,000			-1,162			2,250			-2,250			388			24,226		31-Mar-16
	Total		$	2,015,000		$	-158,131		$	181,350		$	-181,350		$	61,069		$	1,917,940
	Series C
	Issuance		December 31,			Nine Months		September 30,			Nine Months			Nine Months			Nine Months			September 30,		Maturity
	Date		2013			Ended		2014			Ended			Ended			Ended			2014		Date
			Balance			September 30,		Unamortized			September 30,			September 30,			September 30,			Balance, net
						2014		Discount			2014			2014			2014
						Proceeds		Beginning			Accrued			(Payments)			Amortization
									Balance		Interest						of Debt
																	Discount
	22-May-14		$	-		$	50,000	$	-3,000		$	2,141		$	-2,141		$	333		$	47,333	31-May-17
	22-May-14			-			22,500		-1,350			963			-963			150			21,300	31-May-17
	22-May-14			-			22,500		-1,350			963			-963			150			21,300	31-May-17
	25-Aug-14			-			50,000		-3,970			1,000			-1,000			221			46,251	31-Oct-17
	25-Aug-14			-			25,000		-1,985			500			-500			110			23,125	31-Oct-17
	Total		$	-		$	170,000	$	-11,655		$	5,567		$	-5,567		$	964		$	159,309
Schedule of Long-term Debt Instruments	'
	Series B
		September 30,			December 31,
		2014			2013
	Convertible notes Beginning Balance	$	2,015,000		$	2,015,000
	Less: unamortized debt discount		-97,060			-158,131
	Convertible notes principal, net		1,917,940			1,856,869
	Less: Payments in Period		-181,350			-235,300
	Added: Accrued interest		181,350			235,300
	Total Convertible notes, net	$	1,917,940		$	1,856,869
	Less: Short term portion, net		-			-
	Long term portion, net	$	1,917,940		$	1,856,869
	Series C
		September 30,			December 31,
		2014			2013
	Convertible notes Beginning Balance	$	170,000		$	-
	Less: unamortized debt discount		-10,691			-
	Convertible notes principal, net		159,309			-
	Less: Payments in Period		-5,567			-
	Added: Accrued interest		5,567			-
	Total Convertible notes, net	$	159,309		$	-
	Less: Short term portion, net		-			-
	Long term portion, net	$	159,309		$	-
Schedule of Maturities of Long-term Debt	'
	Series B
			Principal			Interest		Amortization
			Payments			Payments		of Discount
	2014		$	-		$	60,450	$	20,357
	2015			1,865,000			241,800		75,155
	2016			150,000			4,500		1,550
	2017			-			-		-
	2018			-			-		-
	Total		$	2,015,000		$	306,750	$	97,062
	Series C
			Principal			Interest		Amortization
			Payments			Payments		of Discount
	2014		$	-		$	5,100	$	971
	2015			-			17,000		3,885
	2016			-			17,000		3,885
	2017			170,000			4,750		1,950
	2018			-			-		-
	Total		$	170,000		$	43,850	$	10,691
	Individually Issued
			Principal			Interest		Amortization
			Payments			Payments		of Discount
	2014		$	15,000		$	5,466	$	2,125
	2015			60,000			27,884		8,500
	2016			60,000			20,748		8,500
	2017			140,000			2,625		2,125
	2018			-			-		-
	Total		$	275,000		$	56,723	$	21,250

Related_Party_Transaction_Tabl

Related Party Transaction (Tables)	9 Months Ended
	Sep. 30, 2014
Related Party Transactions [Abstract]	'
Schedule of Related Party Transactions	'
		Shareholder		Shareholder
		Note		Convertible Note
	Balance at January 1, 2013	$	7,062	$	10,936
	Added: Accrued Interest		-		48
	Less: Foreign Exchange Gain		-		693
	Less: Payments		-7,062		-10,291
	Balance at December 31, 2013	$	-	$	-
	Balance at September 30, 2014	$	-	$	-

Major_Customers_Tables

Major Customers (Tables)	9 Months Ended
	Sep. 30, 2014
Major Customers	'
Schedule of Revenue by Major Customers	'
			Nine Months Ended				Nine Months Ended
			30-Sep-14				30-Sep-13
	Customers		Revenue		Revenue		Revenue		Revenue
			amount		percentage		amount		percentage
	Contract A		$	650,079	17%		$	850,749	22%
	Contract E			698,618	18%			791,039	21%
	Contract F			430,257	11%			427,108	11%
	Contract H		$	247,239	7%		$	206,705	5%
Schedule of Accounts Receivable by Major Customers	'
	Balance at				Balance at
	30-Sep-14				31-Dec-13
	Accounts			Accounts	Accounts			Accounts
	Receivable			Receivable	Receivable			Receivable
	Closing Balance			Percentage	Closing Balance			Percentage
	$	-		0%	$	17,876		6%
		100,834		23%		95,552		34%
		45,849		10%		46,796		17%
	$	30,850		7%	$	54,757		19%

Organization_and_Summary_of_Si2

Organization and Summary of Significant Accounting Policies - Basic and Diluted Earners Per Share (Details) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Numerator	'	'	'	'
Total comprehensive income (loss)	($15,777)	$7,590	($65,323)	($90,067)
Denominator	'	'	'	'
Weighted average number of shares outstanding - basic and diluted	23,850,828	23,421,481	23,688,366	23,326,973
Earnings per Share	'	'	'	'
Basic earnings per share from total comprehensive income (loss)	($0.00)	$0	($0.00)	($0.00)
Diluted earnings per share from total comprehensive income (loss)	($0.00)	$0	($0.00)	($0.00)

Organization_and_Summary_of_Si3

Organization and Summary of Significant Accounting Policies (Details Narrative) (USD $)	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2012
Accounts Receivable, Net, Current	'	'	'	'	'	'
Allowance for bad debts	$31,583	'	$31,583	'	$17,294	'
Bad debt expense (recapture)	-515	-20,455	14,465	1,283	'	'
Accounts receivable, concentration risk	'	'	33.00%	'	70.00%	'
Goodwill and Indefinite Intangible Assets	'	'	'	'	'	'
Goodwill	1,422,670	'	1,422,670	'	1,422,670	1,422,670
Amortization of Intangible Assets with Finite Useful Lives	'	'	'	'	'	'
Accumulated amortization	-133,245	'	-133,245	'	-905,027	'
Recognized Share-Based Compensation Expense	'	'	'	'	'	'
Stock-based compensation expense	'	'	150	0	'	'
Other Income and (Expenses):	'	'	'	'	'	'
Foreign currency gains (losses)	145	171	954	4,440	'	'
Other comprehensive income (loss) gain	$334	($1,068)	$63	$2,222	'	'

Organization_and_Summary_of_Si4

Organization and Summary of Significant Accounting Policies - PPE Amortization and Depreciation (Details Narrative)	9 Months Ended
	Sep. 30, 2014
Equipment	'
Property, Plant and Equipment [Line Items]	'
Property Plant and Equipment Depreciation Methods	'Straight-line method
Property Plant and Equipment Useful Life	'3 - 7 years
Furniture and Fixtures	'
Property, Plant and Equipment [Line Items]	'
Property Plant and Equipment Depreciation Methods	'Straight-line method
Property Plant and Equipment Useful Life	'5 - 7 years
Hospital Contracts	'
Property, Plant and Equipment [Line Items]	'
Property Plant and Equipment Depreciation Methods	'Straight-line method
Property Plant and Equipment Useful Life	'2 - 5 years
Non-compete Contract	'
Property, Plant and Equipment [Line Items]	'
Property Plant and Equipment Depreciation Methods	'Straight-line method
Property Plant and Equipment Useful Life	'3 - 5 years
Leasehold Improvements	'
Property, Plant and Equipment [Line Items]	'
Property Plant and Equipment Depreciation Methods	'Straight-line method
Property Plant and Equipment Useful Life	'39 years

Property_and_Equipment_Details

Property and Equipment (Details) (USD $)	9 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, accumulated depreciation	($364,165)	($237,763)
Property and equipment, net	1,441,294	1,199,701
Computer/Office Equipment	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	83,654	88,378
Property and equipment, estimated useful lives	'3 - 7 years	'
Medical Equipment	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	878,024	601,774
Property and equipment, estimated useful lives	'3 - 7 years	'
Leasehold Improvements	'	'
Property, Plant and Equipment [Line Items]	'	'
Property and equipment, gross	$843,781	$747,312
Property and equipment, estimated useful lives	'39 years	'

Property_and_Equipment_Details1

Property and Equipment (Details Narrative) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Property, Plant and Equipment [Abstract]	'	'	'	'
Depreciation expense	$50,252	$39,831	$129,907	$118,753
Payments to acquire equipment	276,250	'	'	'
Payment for construction process	$96,470	'	'	'

Business_Combination_Considera

Business Combination - Consideration Transfered (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
Business Combination, Consideration Transferred	'
Cash consideration paid	$1,825,000
Acquisition Liability	200,000
Total consideration paid	$2,025,000

Business_Combination_Recognize

Business Combination - Recognized Identifiable Assets Acquired and Liabilities Assumed (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013	Dec. 31, 2012
Business Combinations [Abstract]	'	'	'
Fair value of cash acquired	$42,887	'	'
Fair value accounts receivable acquired	124,436	'	'
Fair value fixed assets acquired	1,345,647	'	'
Fair value deposits acquired	8,140	'	'
Fair value non-compete agreement acquired	27,917	'	'
Fair value goodwill acquired	1,422,670	1,422,670	1,422,670
Fair value liabilities assumed	-946,697	'	'
Fair value net assets purchased	$2,025,000	'	'

Business_Combination_Details_N

Business Combination (Details Narrative) (USD $)	1 Months Ended		3 Months Ended		9 Months Ended		12 Months Ended
	Oct. 31, 2014	Jun. 30, 2014	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2012	Aug. 28, 2014	Dec. 31, 2013	Dec. 10, 2012
Business Combination, Description	'	'	'	'	'	'	'	'	'	'
Business combination, name of acquired entity	'	'	'	'	'	'	'Schuylkill Open MRI Inc	'	'	'
Business combination, description of acquired entity	'	'	'	'	'	'	'SMI provides Magnetic Resonance Imaging (MRI) services.	'	'	'
Business combination, date of acquisition	'	'	'	'	'	'	10-Dec-12	'	'	'
Business combination, purchase price	$1,800,000	'	'	'	'	'	$1,825,000	'	'	'
Business combination, capital lease agreement	'	'	'	'	'	'	'	'	'	11,013
Business combination, one-time capital lease payment	'	'	'	'	'	'	'	'	'	125,000
Business combination, capital lease, value	'	'	'	'	'	'	'	'	'	555,000
Business combination, goodwill	'	'	1,422,670	'	1,422,670	'	1,422,670	'	1,422,670	'
Business combination, revenue through acquired entity	'	'	1,696,155	1,560,185	1,555,083	1,371,737	'	'	'	'
Business combination, gross earnings through acquired entity	'	'	441,702	345,904	1,169,591	985,272	'	'	'	'
Business combination, costs related to the acquisition	'	200,000	'	'	'	'	81,811	'	'	'
Prospective acquisition, consideration and outcome	'	'	'On August 28, 2014, the Company entered into a Purchase Agreement to purchase three diagnostic imaging businesses for an aggregate purchase price of $1.8 million.	'	'	'	'	'	'	'
Prospective acquisition, deposit	'	'	$32,615	'	$32,615	'	'	$20,000	$12,855	'

Goodwill_Details

Goodwill (Details) (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Goodwill [Roll Forward]	'	'
Goodwill, balance at beginning of period	$1,422,670	$1,422,670
Changes in Goodwill	0	0
Goodwill, balance at end of period	$1,422,670	$1,422,670

Lease_Commitments_Details

Lease Commitments (Details) (USD $)	Sep. 30, 2014
Office Space	'
Operating Leased Assets [Line Items]	'
Year 2014	$47,853
Year 2015	176,012
Year 2016	179,532
Servers	'
Operating Leased Assets [Line Items]	'
Year 2014	7,776
Year 2015	18,000
Year 2016	18,000
Lease Commitments	'
Operating Leased Assets [Line Items]	'
Year 2014	55,629
Year 2015	194,012
Year 2016	$197,532

Lease_Commitments_Details_Narr

Lease Commitments (Details Narrative) (USD $)	9 Months Ended
	Sep. 30, 2014
CTS - Office Space	'
Operating Leased Assets [Line Items]	'
Operating lease, minimum payments	$5,300
Leasing arrangements	'CTS has a lease commitment for its office space of approximately $2,450 minimum rental, and approximately $2,850 in utilities, realty taxes, and operating costs. The Lease renewed in April 2013 for a period of five years and will expire in March 2018.
Rental credit	28,000
CTS - Off Site Servers	'
Operating Leased Assets [Line Items]	'
Operating lease, minimum payments	1,500
Leasing arrangements	'CTS has a lease for its off-site servers. The lease will expire in April 30, 2017.
SMI - Off Site Server	'
Operating Leased Assets [Line Items]	'
Operating lease, minimum payments	1,092
Leasing arrangements	'SMI has a lease for its off-site servers. The lease is accounted for as an operating lease on a month-to-month basis.
SMI - Office Space - Pottsville, Pennsylvania	'
Operating Leased Assets [Line Items]	'
Operating lease, minimum payments	7,111
Leasing arrangements	'SMI entered into a lease commitment for its office space in Pottsville, Pennsylvania. The lease will expire on June 30, 2016, and it is renewable for an additional term of 5 years on the same terms and conditions. The lease was amended to include the additional space of 700 square feet occupied by the CT machine and equipment. The first additional rental payment will begin in July of 2015; the additional rental amount is expected to be approximately $1,100.
SMI - Office Space - Dallas, Texas	'
Operating Leased Assets [Line Items]	'
Operating lease, minimum payments	1,540
Leasing arrangements	'SMI has a lease for its off-site servers. The lease will expire in February 28, 2015.
SMI - Sublease	'
Operating Leased Assets [Line Items]	'
Operating lease, minimum payments	$2,000
Leasing arrangements	'SMI has entered into a sublease agreement for approximately one hundred fifty (150) square feet of space for the use of operating the x-ray machine as well as use of common areas of the sublessor. The lease will expire in October 01, 2021.

Accounts_Payable_and_Accrued_L1

Accounts Payable and Accrued Liabilities (Details Narrative) (USD $)	Sep. 30, 2014	Dec. 31, 2013
TradePayablesAndAccruedLiabilitiesLineItems [Line Items]	'	'
Trade payables and accrued expenses	$723,551	$608,151
CTS - Ongoing Operations	'	'
TradePayablesAndAccruedLiabilitiesLineItems [Line Items]	'	'
Trade payables and accrued expenses	252,350	301,965
SMI - Ongoing Operations	'	'
TradePayablesAndAccruedLiabilitiesLineItems [Line Items]	'	'
Trade payables and accrued expenses	$400,551	$278,854

Obligations_Under_Capital_Leas2

Obligations Under Capital Lease (Details) (USD $)	Sep. 30, 2014	Dec. 31, 2013
Capital Leases Future Minimum Payments Due Rolling Maturity	'	'
Obligations Under Capital Lease, long term portion	$216,276	$228,495
Capital Lease - MRI Machines	'	'
Capital Leases Future Minimum Payments Due Rolling Maturity	'	'
Minimum future lease payments, 2014	33,038	'
Minimum future lease payments, 2015	132,152	'
Minimum future lease payments, 2016	132,151	'
Total minimum lease payments	297,341	'
Less amount representing interest	33,580	'
Present value of minimum lease payments	263,761	'
Less current portion of minimum lease payments	-109,599	'
Obligations Under Capital Lease, long term portion	154,162	'
Capital Lease - X-Ray Machine	'	'
Capital Leases Future Minimum Payments Due Rolling Maturity	'	'
Minimum future lease payments, 2014	4,486	'
Minimum future lease payments, 2015	17,944	'
Minimum future lease payments, 2016	17,944	'
Minimum future lease payments, 2017	17,944	'
Minimum future lease payments, 2018	17,944	'
Minimum future lease payments, 2019	11,963	'
Total minimum lease payments	88,225	'
Less amount representing interest	12,561	'
Present value of minimum lease payments	75,664	'
Less current portion of minimum lease payments	-13,550	'
Obligations Under Capital Lease, long term portion	$62,114	'

Obligations_Under_Capital_Leas3

Obligations Under Capital Lease (Details Narrative) (USD $)	3 Months Ended	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Sep. 30, 2014	Dec. 31, 2012
Capital Lease - MRI Machines	'	'	'
Capital Leased Assets [Line Items]	'	'	'
Capital leases, equipment, gross	$555,000	$555,000	'
Capital leases, equipment, net	351,583	351,583	'
Capital leases, amortization expense	'	203,417	'
Amortization of leased assets	27,750	83,250	'
Capital leases, leasing arrangements	'	'	'The Company entered into a lease agreement with one of the sellers of SMI to lease the two MRI machines. Under the terms of the lease, SMI is to make monthly payments of $11,013, plus applicable sales tax, over a period of 48 months. In addition, SMI agreed to make a one-time lease payment of $125,000, which was paid by March 30, 2013. The Company has guaranteed all of SMI's obligations under the lease. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00.
Capital Lease - X-Ray Machine	'	'	'
Capital Leased Assets [Line Items]	'	'	'
Capital leases, equipment, gross	78,250	78,250	'
Capital leases, equipment, net	74,337	74,337	'
Capital leases, amortization expense	3,913	3,913	'
Capital leases, accumulated amortization	$3,913	$3,913	'
Capital leases, leasing arrangements	'The Company has entered into a capital lease agreement to lease the x-ray machine that was delivered and installed in July 2014. Under the terms of the lease, the Company's subsidiary, SMI, is to make monthly payments of $1,495, plus applicable sales tax, over a period of 60 months. At the end of the lease, SMI will have the option to purchase the MRI machines for a total purchase price of $1.00.	'	'

Promissory_Notes_Details

Promissory Notes (Details) (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Promissory Notes [Roll Forward]	'	'
Promissory notes, beginning of period	$45,015	$119,624
Proceeds from notes issuances	'	6,000
Promissory note assigned	64,937	'
Accrued interest	3,823	6,616
Payments through end of period	-26,483	-87,225
Promissory notes, end of period	87,292	45,015
Promissory notes, short-term portion	79,543	'
Promissory notes, long-term portion	$7,749	$17,472

Promissory_Notes_Details_Narra

Promissory Notes (Details Narrative) (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Other Liabilities Disclosure [Abstract]	'	'
Promissory note, accrued interest	$3,823	$6,616
Promissory note, payments through end of period	-26,483	-87,225
Promissory note, assumed on acquisition	'	64,528
Promissory note, accrued interest rate, terms	'	'$18,736 of the notes assumed on acquisition represented by a promissory note accruing interest at an annual rate of 10.5% and paid out monthly. $45,792 of the notes assumed on acquisition represented by a promissory note accruing interest at an annual rate of 6% and paid out monthly.
Promissory note, assigned	$64,937	'
Promissory note, interest rate	12.00%	'
Promissory note, maturity date	1-Feb-15	'

Convertible_Notes_Details_of_S

Convertible Notes - Details of Series B and C Notes (Details) (USD $)	9 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Debt Instrument [Line Items]	'	'
Convertible note, maturity date	1-Feb-15	'
Series B - Note 1	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	3-Dec-12	'
Convertible note, beginning balance	$25,000	'
Convertible note, accrued interest	2,250	'
Convertible note, payments	-2,250	'
Convertible note, amortization of debt discount	281	'
Convertible note, unamortized debt discount	'	-719
Convertible note, ending balance	24,562	'
Convertible note, maturity date	31-Dec-15	'
Series B - Note 2	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	3-Dec-12	'
Convertible note, beginning balance	125,000	'
Convertible note, accrued interest	11,250	'
Convertible note, payments	-11,250	'
Convertible note, amortization of debt discount	3,731	'
Convertible note, unamortized debt discount	'	-10,569
Convertible note, ending balance	118,162	'
Convertible note, maturity date	31-Dec-15	'
Series B - Note 3	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	3-Dec-12	'
Convertible note, beginning balance	50,000	'
Convertible note, accrued interest	4,500	'
Convertible note, payments	-4,500	'
Convertible note, amortization of debt discount	844	'
Convertible note, unamortized debt discount	'	-2,156
Convertible note, ending balance	48,688	'
Convertible note, maturity date	31-Dec-15	'
Series B - Note 4	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	3-Dec-12	'
Convertible note, beginning balance	25,000	'
Convertible note, accrued interest	2,250	'
Convertible note, payments	-2,250	'
Convertible note, amortization of debt discount	281	'
Convertible note, unamortized debt discount	'	-719
Convertible note, ending balance	24,562	'
Convertible note, maturity date	31-Dec-15	'
Series B - Note 5	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	3-Dec-12	'
Convertible note, beginning balance	25,000	'
Convertible note, accrued interest	2,250	'
Convertible note, payments	-2,250	'
Convertible note, amortization of debt discount	281	'
Convertible note, unamortized debt discount	'	-719
Convertible note, ending balance	24,562	'
Convertible note, maturity date	31-Dec-15	'
Series B - Note 6	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	3-Dec-12	'
Convertible note, beginning balance	25,000	'
Convertible note, accrued interest	2,250	'
Convertible note, payments	-2,250	'
Convertible note, amortization of debt discount	281	'
Convertible note, unamortized debt discount	'	-719
Convertible note, ending balance	24,562	'
Convertible note, maturity date	31-Dec-15	'
Series B - Note 7	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	3-Dec-12	'
Convertible note, beginning balance	1,500,000	'
Convertible note, accrued interest	135,000	'
Convertible note, payments	-135,000	'
Convertible note, amortization of debt discount	50,625	'
Convertible note, unamortized debt discount	'	-129,375
Convertible note, ending balance	1,421,250	'
Convertible note, maturity date	31-Dec-15	'
Series B - Note 8	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	3-Dec-12	'
Convertible note, beginning balance	50,000	'
Convertible note, accrued interest	4,500	'
Convertible note, payments	-4,500	'
Convertible note, amortization of debt discount	844	'
Convertible note, unamortized debt discount	'	-2,156
Convertible note, ending balance	48,688	'
Convertible note, maturity date	31-Dec-15	'
Series B - Note 9	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	3-Dec-12	'
Convertible note, beginning balance	15,000	'
Convertible note, accrued interest	1,350	'
Convertible note, payments	-1,350	'
Convertible note, amortization of debt discount	169	'
Convertible note, unamortized debt discount	'	-431
Convertible note, ending balance	14,738	'
Convertible note, maturity date	31-Dec-15	'
Series B - Note 10	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	3-Dec-12	'
Convertible note, beginning balance	100,000	'
Convertible note, accrued interest	9,000	'
Convertible note, payments	-9,000	'
Convertible note, amortization of debt discount	2,569	'
Convertible note, unamortized debt discount	'	-7,081
Convertible note, ending balance	95,488	'
Convertible note, maturity date	31-Dec-15	'
Series B - Note 11	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	27-Mar-13	'
Convertible note, beginning balance	25,000	'
Convertible note, accrued interest	2,250	'
Convertible note, payments	-2,250	'
Convertible note, amortization of debt discount	388	'
Convertible note, unamortized debt discount	'	-1,162
Convertible note, ending balance	24,226	'
Convertible note, maturity date	31-Mar-16	'
Series B - Note 12	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	27-Mar-13	'
Convertible note, beginning balance	25,000	'
Convertible note, accrued interest	2,250	'
Convertible note, payments	-2,250	'
Convertible note, amortization of debt discount	388	'
Convertible note, unamortized debt discount	'	-1,162
Convertible note, ending balance	24,226	'
Convertible note, maturity date	31-Mar-16	'
Series B - Note 13	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	27-Mar-13	'
Convertible note, beginning balance	25,000	'
Convertible note, accrued interest	2,250	'
Convertible note, payments	-2,250	'
Convertible note, amortization of debt discount	388	'
Convertible note, unamortized debt discount	'	-1,162
Convertible note, ending balance	24,226	'
Convertible note, maturity date	31-Mar-16	'
Series C - Note 1	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	22-May-14	'
Convertible note, beginning balance	0	'
Convertible note, proceeds	50,000	'
Convertible note, accrued interest	2,141	'
Convertible note, payments	-2,141	'
Convertible note, amortization of debt discount	333	'
Convertible note, unamortized debt discount	-3,000	'
Convertible note, ending balance	47,333	'
Convertible note, maturity date	31-May-17	'
Series C - Note 2	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	22-May-14	'
Convertible note, beginning balance	0	'
Convertible note, proceeds	22,500	'
Convertible note, accrued interest	963	'
Convertible note, payments	-963	'
Convertible note, amortization of debt discount	150	'
Convertible note, unamortized debt discount	-1,350	'
Convertible note, ending balance	21,300	'
Convertible note, maturity date	31-May-17	'
Series C - Note 3	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	22-May-14	'
Convertible note, beginning balance	0	'
Convertible note, proceeds	22,500	'
Convertible note, accrued interest	963	'
Convertible note, payments	-963	'
Convertible note, amortization of debt discount	150	'
Convertible note, unamortized debt discount	-1,350	'
Convertible note, ending balance	21,300	'
Convertible note, maturity date	31-May-17	'
Series C - Note 4	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	25-Aug-14	'
Convertible note, beginning balance	0	'
Convertible note, proceeds	50,000	'
Convertible note, accrued interest	1,000	'
Convertible note, payments	-1,000	'
Convertible note, amortization of debt discount	221	'
Convertible note, unamortized debt discount	-3,970	'
Convertible note, ending balance	46,251	'
Convertible note, maturity date	31-Oct-17	'
Series C - Note 5	'	'
Debt Instrument [Line Items]	'	'
Convertible note, issuance date	25-Aug-14	'
Convertible note, beginning balance	0	'
Convertible note, proceeds	25,000	'
Convertible note, accrued interest	500	'
Convertible note, payments	-500	'
Convertible note, amortization of debt discount	110	'
Convertible note, unamortized debt discount	-1,985	'
Convertible note, ending balance	$23,125	'
Convertible note, maturity date	31-Oct-17	'

Convertible_Notes_Summary_of_S

Convertible Notes - Summary of Series B, C and Individually Issued Notes (Details) (USD $)	9 Months Ended	12 Months Ended
	Sep. 30, 2014	Dec. 31, 2013
Series B - Convertible Notes	'	'
Debt Instrument [Line Items]	'	'
Convertible notes, beginning of period	$2,015,000	$2,015,000
Less: unamortized debt discount	-97,060	-158,131
Convertible notes principal, net	1,917,940	1,856,869
Less: Payment in period	-181,350	-235,300
Added: Accrued interest	181,350	235,300
Total convertible notes, net	1,917,940	1,856,869
Less: Short term portion, net	0	0
Long term portion, net	1,917,940	1,856,869
Series C - Convertible Notes	'	'
Debt Instrument [Line Items]	'	'
Convertible notes, beginning of period	170,000	0
Less: unamortized debt discount	-10,691	0
Convertible notes principal, net	159,309	0
Less: Payment in period	-5,567	0
Added: Accrued interest	5,567	0
Total convertible notes, net	159,309	0
Less: Short term portion, net	0	0
Long term portion, net	159,309	0
Individually Issued Convertible Note	'	'
Debt Instrument [Line Items]	'	'
Convertible notes, beginning of period	300,000	0
Less: unamortized debt discount	-21,250	0
Convertible notes principal, net	278,750	0
Less: Payment in period	-43,337	0
Added: Accrued interest	18,337	0
Total convertible notes, net	253,750	0
Less: Short term portion, net	54,070	0
Long term portion, net	$199,680	$0

Convertible_Notes_LongTerm_Deb

Convertible Notes - Long-Term Debt Maturities (Details) (USD $)	9 Months Ended
	Sep. 30, 2014
Series B Notes - Long-Term Debt Maturities	'
Debt Instrument [Line Items]	'
Principal payments, 2014	$0
Principal payments, 2015	1,865,000
Principal payments, 2016	150,000
Principal payments, 2017	0
Principal payments, 2018	0
Interest payments, 2014	60,450
Interest payments, 2015	241,800
Interest payments, 2016	4,500
Interest payments, 2017	0
Interest payments, 2018	0
Amortization expense, 2014	20,357
Amortization expense, 2015	75,155
Amortization expense, 2016	1,550
Amortization expense, 2017	0
Amortization expense, 2018	0
Series C Notes - LongTerm Debt Maturities	'
Debt Instrument [Line Items]	'
Principal payments, 2014	0
Principal payments, 2015	0
Principal payments, 2016	0
Principal payments, 2017	170,000
Principal payments, 2018	0
Interest payments, 2014	5,100
Interest payments, 2015	17,000
Interest payments, 2016	17,000
Interest payments, 2017	4,750
Interest payments, 2018	0
Amortization expense, 2014	971
Amortization expense, 2015	3,885
Amortization expense, 2016	3,885
Amortization expense, 2017	1,950
Amortization expense, 2018	0
Non-Affiliate Issued Convertible Note	'
Debt Instrument [Line Items]	'
Principal payments, 2014	15,000
Principal payments, 2015	60,000
Principal payments, 2016	60,000
Principal payments, 2017	140,000
Principal payments, 2018	0
Interest payments, 2014	5,466
Interest payments, 2015	27,884
Interest payments, 2016	20,748
Interest payments, 2017	2,625
Interest payments, 2018	0
Amortization expense, 2014	2,125
Amortization expense, 2015	8,500
Amortization expense, 2016	8,500
Amortization expense, 2017	2,125
Amortization expense, 2018	$0

Convertible_Notes_Details_Narr

Convertible Notes (Details Narrative) (USD $)	3 Months Ended		9 Months Ended			12 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014	Sep. 30, 2014
					Convertible Notes - Series B	Convertible Notes - Series B	Convertible Notes - Series C	Individual - Convertible Note
Debt Instrument [Line Items]	'	'	'	'	'	'	'	'
Convertible notes, sold	'	'	'	'	'	$150,000	$75,000	$300,000
Convertible notes, payment terms	'	'	'	'	'	'Series B Notes pay interest at a rate of 12% per annum, payable to the holder at 1% per month.	'Series C Notes bear interest at a rate of 12% per annum, payable to the holder at 1% per month, with principal amount due May 31, 2017.	'The note pays interest at a rate of 12% per annum, payable to the holder at 1% per month. The Company will also be making monthly payments of $5,000 towards the principal balance beginning June 1, 2014 for 3 years until the note due date of February 27, 2017.
Convertible notes, price per share for conversion of shares of common stock	'	'	'	'	'	$0.10	$0.15	$0.15
Note holder additions	'	'	'	'	'	'	'	'The non-affiliate will receive 300,000 shares as part of the note agreement.
Additional paid in capital and discount	'	'	'	'	244,275	244,275	11,655	25,500
Amortization of debt discount	23,287	20,356	66,283	59,519	61,069	'	964	4,250
Convertible note, accrued interest	'	'	'	'	181,350	'	5,568	18,337
Private placement, 12% convertible notes (Series B Notes), principal amount	'	'	'	'	'	$1,865,000	$95,000	'
Private placement, maturity date, description	'	'	'	'	'	'Series B Notes issued December 3, 2012 for $1,865,000 mature on December 31, 2013 and Series B Notes issued March 27, 2013 for $150,000 mature on March 31, 2016.	'	'
Private placement, maturity date	'	'	'	'	'	'	31-May-17	27-Feb-17
Common stock issued	'	'	'	'	'	5,315,000	170,000	300,000

Related_Party_Transactions_Det

Related Party Transactions (Details) (USD $)	12 Months Ended		12 Months Ended		12 Months Ended
	Dec. 31, 2013	Jun. 30, 2010	Dec. 31, 2013	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014
			Officer and Shareholder	Officer and Shareholder	Officer and Shareholder	Officer and Shareholder
			Notes	Notes	Convertible Note	Convertible Note
Related Party Transaction [Line Items]	'	'	'	'	'	'
Related party notes, beginning balance	'	'	$7,062	'	$10,936	'
Related party notes, accrued interest	48	'	'	'	48	'
Related party notes, foreign exchange loss	693	'	'	'	693	'
Related party notes, payments	'	'	-7,062	'	-10,291	'
Related party notes, ending balance	'	$42,944	$0	$0	$0	$0

Related_Party_Transactions_Det1

Related Party Transactions (Details Narrative) (USD $)	9 Months Ended		12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Jun. 30, 2010
Related Party Transactions [Abstract]	'	'	'	'
Related party notes, payments	$0	$10,291	($7,062)	'
Related party loan	'	'	'	42,944
Related party notes, foreign exchange loss	'	'	693	'
Related party notes, accrued interest	'	'	$48	'

Major_Customers_Details

Major Customers (Details) (USD $)

9 Months Ended

12 Months Ended

9 Months Ended

9 Months Ended

9 Months Ended

9 Months Ended

Sep. 30, 2014

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Sep. 30, 2014

Sep. 30, 2013

Dec. 31, 2013

Contract A

Contract A

Contract A

Contract E

Contract E

Contract E

Contract F

Contract F

Contract F

Contract H

Contract H

Contract H

Revenue, Major Customer [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Major customer revenues

'

'

$650,079

$850,749

'

$698,618

$791,039

'

$430,257

$427,108

'

$247,239

$206,705

'

Major customer percent of revenue

33.00%

70.00%

17.00%

22.00%

'

18.00%

21.00%

'

11.00%

11.00%

'

7.00%

5.00%

'

Major customers accounts receivable closing balance

'

'

$0

'

$17,876

$100,834

'

$95,552

$45,849

'

$46,796

$30,850

'

$54,757

Major customers accounts receivable percentage

'

'

0.00%

'

6.00%

23.00%

'

34.00%

10.00%

'

17.00%

7.00%

'

19.00%

Major_Vendors_Details_Narrativ

Major Vendors (Details Narrative) (USD $)	3 Months Ended
	Sep. 30, 2014	Sep. 30, 2013
Major Vendors	'	'
Expenses for system software and support	$14,190	$14,560

Common_Stock_Transactions_Deta

Common Stock Transactions (Details Narrative) (USD $)	9 Months Ended		12 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Dec. 31, 2013	Dec. 31, 2012
Equity [Abstract]	'	'	'	'
Shares issued, convertible notes, shares	300,000	'	300,000	5,015,000
Shares issued, convertible notes, value	$25,500	'	$18,600	$225,675
Shares issued, Series C convertible notes, shares	170,000	'	'	'
Shares issued, Series C convertible notes, value	11,655	'	'	'
Shares issued for services, shares	5,000	'	'	'
Shares issued for services, value	$150	$0	'	'

Going_Concern_Details_Narrativ

Going Concern (Details Narrative) (USD $)	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Going Concern	'	'	'	'
Total Comprehensive Income (Loss)	($15,777)	$7,590	($65,323)	($90,067)
Working capital deficit	$427,696	'	$427,696	'

Subsequent_Events_Details_Narr

Subsequent Events (Details Narrative) (USD $)	1 Months Ended	12 Months Ended
	Oct. 31, 2014	Dec. 31, 2012
Subsequent Event [Line Items]	'	'
Business combination, purchase price	$1,800,000	$1,825,000
Subsequent Event | Business Acquisitions	'	'
Subsequent Event [Line Items]	'	'
Business combination, purchase price	1,800,000	'
Credit facility	2,000,000	'
Subsequent Event | Series C Notes - Non-Affiliate	'	'
Subsequent Event [Line Items]	'	'
Proceeds from issuance of convertible notes	$50,000	'
Shares issued with convertible notes, shares	50,000	'